Baranov V G, Nechaĭ A I, Trofimov V M, Savushkina A S, Kalashnikov S A
Probl Endokrinol (Mosk). 1986 Nov-Dec;32(6):3-11.
Proceeding from a study of the results of the investigation of 152 patients with Icenko-Cushing's syndrome the authors have arrived at the conclusion that hyperplasia, clear cell adenoma of monomorphous structure, dark cell and mixed adenomas of polymorphous structure, cancer of the adrenal cortex are different stages of a common pathological process. Such formation of morphological changes in the adrenal gland is one of the ways of development of Icenko-Cushing's syndrome. To confirm the proposed concept of the pathogenesis of this disease the authors provide some evidence of hyperplasia or the normal structure of nontumorous adrenocortical tissue in adenoma and cancer, of the absence of difference in a rise of the mean ACTH level in the blood in hyperplasia and different adrenocortical tumors. An increase in ACTH production in most of the patients should be regarded as one of the primary factors of the above morphological changes. The absence of suppression of 17-oxycorticosteroid excretion with urine in a test with 8 mg of dexamethasone in most of the patients with dark cell and mixed adenoma of polymorphous structure and adrenocortical cancer suggests a possibility of the development of certain autonomy of these neoplasms.
基于对152例艾兴科-库欣综合征患者的调查结果研究,作者得出结论:肾上腺皮质增生、单形结构的透明细胞腺瘤、多形结构的暗细胞及混合性腺瘤、肾上腺皮质癌是一个共同病理过程的不同阶段。肾上腺形态学变化的这种形成方式是艾兴科-库欣综合征发展的途径之一。为证实所提出的该疾病发病机制的概念,作者提供了一些证据,如腺瘤和癌中非肿瘤性肾上腺皮质组织的增生或正常结构、增生及不同肾上腺皮质肿瘤患者血液中促肾上腺皮质激素(ACTH)平均水平升高无差异。大多数患者促肾上腺皮质激素分泌增加应被视为上述形态学变化的主要因素之一。大多数多形结构暗细胞及混合性腺瘤和肾上腺皮质癌患者在8毫克地塞米松试验中尿17-氧皮质类固醇排泄未受抑制,提示这些肿瘤可能发展出一定的自主性。